Results 21 to 30 of about 141,527 (280)

Monotherapy versus combination therapy in the treatment of benign prostatic hyperplasia: A single center study

Zanco Journal of Medical Sciences, 2020
Background and objectives: Most benign prostatic hyperplasia patients do not present obvious indicators for surgical intervention, so most of these patients are treated initially with medical therapy.
Wishyar Jamal Al-Bazzaz, Omar W. Alkhayat, Ali W. AlKhayat W. AlKhayat   +2 more
doaj   +1 more source

Benign prostatic hyperplasia [PDF]

Revista da Associação Médica Brasileira, 2018
The minimally invasive procedures (mips) for the treatment of symptoms of benign prostatic hyperplasia (bph) are presented as attractive techniques due to their ease of accomplishment and the possibility of outpatient treatment. This guideline aims to present recommendations that may assist in decision making in patients with benign prostatic ...
Ricardo L. V. Nunes, Alberto A. Antunes, Antonio Silvinato, Wanderley M. Bernardo   +3 more
openaire   +4 more sources

Interstitial laser therapy of benign prostatic hyperplasia [PDF]

, 1999
The objective of interstitial laser coagulation (ILC) of benign prostatic enlargement is to achieve a marked volume reduction and to decrease bladder outlet obstruction and lower urinary tract symptoms with minimal morbidity.
Muschter, Rolf, Whitfield, Hugh
core   +1 more source

Effect of heat exposure on viability and contractility of cultured prostatic stromal cells [PDF]

, 2000
Objectives: Different thermotherapeutic modalities such as transurethral microwave therapy or transurethral needle ablation have been developed to provide effective alternatives to surgical management of benign prostate hyperplasia (BPH).
Corvin, Stefan, Maneschg, Christoph, Klocker, Helmut, Radmayr, Christian, Boesch, Simone, Bartsch, Georg   +5 more
core   +1 more source

Urinary cholesterol excretion in men with benign prostatic hyperplasia and carcinoma of the prostate [PDF]

, 1966
Urinary excretion of nonesterified (NEC) and total cholesterol (TC) has been investigated in 79 patients with prostatic adenoma (BPH) and 48 patients with carcinoma of the prostate.
P. GIORDANO, Odom, Lorrie F., Ruiz Jorge, Lissette, Williams, Fiona L. R., Llombart-Bosh, Antonio, Angelika, Pickel, McNeely, Lee K., McCarthy, Donna O., Roy, S., Meagher, David P., Jr., G. MAZZINI, Kumar, Lalit, Bhangui, G. R., Daniel, William E., Lloyd, Owen L., Tandon, P. N., Alegret Rodríguez, Milagros, Pickel, A., Kochupillai, V., Elsässer, Erich, Machado Puerto, Isidro, Karl, Hans Josef, E. TRAVERSI, Dua, Harsch, Stadler, Alexander, Cowpe, Jonathan G., Green, Michael, Jüngst, Dieter, Blake, Marilyn, Marx, Franz J., Poole, Marten A., Haase, Gerald M., Ogden, Graham R.; id_orcid, E. ASCARI, MONTECUCCO, CARLOMAURIZIO, A. RICCARDI, Moskowitz, M., Grill, J. P., G. IPPOLITI, Ingle, J. N., Stanley, R. J., Zimmerman, R. R., Kushner, H. D., Schild, S. E., Thompson, W. M., Schaid, D. J., Roche, P. C., Smart, C. R., Krammer, B., Buskirk, S. J., Holleb, A. I., McLelland, R., INVERNIZZI, ROSANGELA, Van Wijnen, Andre J., Su, J. Q., Lian, Jane B., Shapiro, Stephanie, Krook, J. E., Maihle, N. J., Olsen, K. D., M. DANOVA, M. GIRINO, Fragoyannis, S, Costanza, Mary E., Foote, R. L., Stein, Janet L., F. PASQUALI, Henson, D. E., Witzig, T. E., Kunselman, S. J., Wall, James, Hartmann, L. C., G. UCCI, Hutter, R. V., Kung'u, A., Wold, L. E., Farr, G. H., Sperry, Kris, Yalcin, S, Stein, Gary S., Pollack, Alan, Zagars, Gunar K, Kavadi, Vivek S   +82 more
core   +2 more sources

Hepsin immunohistochemical expression in prostate cancer in relation to Gleason′s grade and serum prostate specific antigen

Indian Journal of Pathology and Microbiology, 2011
Background: Hepsin (HPN), a type II trans-membrane serine protease, has been reported to be one of the most up regulated genes in prostate cancer. The aim of the present study was to find out immuno-histochemistry based phenotypic expression of HPN in ...
Madhu Mati Goel, Dhamita Agrawal, S M Natu, Apul Goel   +3 more
doaj   +1 more source

Treatment options in benign prostate hyperplasia associated with lower urinary tract symptoms

Urology Research and Practice, 2019
Benign prostatic hyperplasia is a common cause of lower urinary tract symptoms. Men who are treated for benign prostatic hyperplasia potentially reduce their lifetime risk of acute urinary retention and the need for benign prostatic hyperplasia-related ...
Ali Atan, Altuğ Tuncel
doaj   +1 more source

DECOMPENSATED URINARY BLADDER DUE TO BENIGN PROSTATIC HYPERPLASIA (LITERATURE REVIEW)

Проблеми екології та медицини, 2022
We conducted an analytical review of the literature on the problem of bladder decompensation in patients with benign prostatic hyperplasia. Benign prostatic hyperplasia is one of the most common diseases in aging men. As is known, with the development of
O.O. Sherstyuk, Y.V. Sarychev, S.M. Suprunenko, S.A. Sukhomlin, G.L. Pustovoit   +4 more
doaj   +1 more source

Prostatic Hyperplasia [PDF]

The Journal of Urology, 1998
This study was designed to investigate whether GH and insulin-like growth factor I (IGF-I) excess could lead to the development of benign prostatic hyperplasia and/or prostatic carcinoma. Prostatic diameters and volume as well as the occurrence of prostatic diseases were studied by ultrasonography in 10 untreated acromegalic patients less than 40 yr of
COLAO, ANNAMARIA, P. Marzullo, D. Ferone, S. Spiezia, G. Cerbone, V. Marinò, DI SARNO, ANTONELLA, MEROLA, BARTOLOMEO, LOMBARDI, GAETANO   +8 more
openaire   +5 more sources

Randomised controlled trial of an interactive multimedia decision aid on benign prostatic hypertrophy in primary care [PDF]

, 2001
Objective To determine whether a decision aid on benign prostatic hypertrophy influences decision making, health outcomes, and resource use.Design Randomised controlled trial.Setting 33 general practices in the United Kingdom.Participants 112 men with ...
Davis, H, Haines, A, Coulter, A, Gray, A, Murray, E, Tai, SS   +5 more
core   +1 more source